Phase 3 Cornea Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Corneal EdemaCorneal Endothelial DysfunctionFuchs Endothelial Corneal Dysfunction+1 more
Aurion Biotech120 enrolled12 locationsNCT07368959
Recruiting
Phase 3
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
KeratoconusEctasia of CorneaPellucid Marginal Corneal Degeneration+1 more
Woolfson Eye Institute485 enrolled12 locationsNCT07124910
Recruiting
Phase 3
Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
corneal ulcerFungal Keratitis
University of California, San Francisco150 enrolled2 locationsNCT06658002
Recruiting
Phase 2Phase 3
Comparison of Standard vs. Accelerated Corneal Crosslinking
KeratoconusEctasia Corneal
Price Vision Group510 enrolled1 locationNCT03922542
Recruiting
Phase 2Phase 3
Corneal Crosslinking for Treatment of Corneal Neovascularization
Corneal Neovascularization
Price Vision Group62 enrolled1 locationNCT04787471
Recruiting
Phase 3
Effects of Topical Insulin on Corneal Epithelium Healing After Corneal Crosslinking in Patients With Keratoconus
Wound HealEye DiseasesKeratoconus+1 more
University of Campinas, Brazil36 enrolled1 locationNCT06601101